150 PDB 1z92 EBI
150 PDB 1z92 EBIhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/150-pdb-1z92-ebi-image214978029.html
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-il-2-cytokine-protein-aldesleukin-is-a-recombinant-analog-141180727.html
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-il-2-cytokine-protein-aldesleukin-is-a-recombinant-analog-141180712.html
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-il-2-cytokine-protein-aldesleukin-is-a-recombinant-analog-141180707.html
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-il-2-cytokine-protein-aldesleukin-is-a-recombinant-analog-141180731.html
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-il-2-cytokine-protein-aldesleukin-is-a-recombinant-analog-141180730.html
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.
Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-il-2-cytokine-protein-aldesleukin-is-a-recombinant-analog-141180744.html
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-receptor-alpha-chain-cd25-extracellular-domain-cd25-141180008.html
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-receptor-alpha-chain-cd25-extracellular-domain-cd25-141180022.html
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-receptor-alpha-chain-cd25-extracellular-domain-cd25-141180011.html
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-receptor-alpha-chain-cd25-extracellular-domain-cd25-141180010.html
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-receptor-alpha-chain-cd25-extracellular-domain-cd25-141180032.html
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-receptor-alpha-chain-cd25-extracellular-domain-cd25-141180033.html
|